Major Histocompatibility Complex (MHC) Factors Predisposing to and Protecting Against Graves' Eye Disease

References

• Volpe R. Autoimmune thyroid disease — a perspective. Mol Biol Med 1986; 3: 25–51
   Google Scholar
• Farid N R. Familial goitre. The thyroid gland. A practical clinical treatise, L. Van Middlesworth. Year Book Med Pub1 Inc., Chicago 1986; 179–201
   Google Scholar
• Wall J R. Autoimmunity and Graves' ophthalmopathy. The Eye and Orbit in Thyroid Diseuse, C Gorman, J Dyer, R Waller. Raven Press, New York 1984; 103–145
   Google Scholar
• Kendall-Taylor P. The pathogenesis of Graves' ophthalmopathy. Clin Endocrinol Metab 1985; 14: 331–349
   Google Scholar
• Forrester J V, Sutherland G R, McDougall I R. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J Clin Endocrinol Metab 1977; 45: 221–224
   PubMed Web of Science ®Google Scholar
• Enzman D R, Donaldson S S, Kriss J P. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr 1978; 3: 815–819
   Google Scholar
• Brownie B EW, Newton O AG, Singh S P. Ophthalmopathy associated with primary hypothyroidism. Acta Endocrinol (Copenh) 1975; 79: 691–699
   Google Scholar
• Gamblin G T, Harper D G, Galentine P, Buck D, Chernon B, Eil C. Prevalence of increased intraocular pressure in Graves' disease — evidence of frequent subclinical ophthalmopathy. N Engl J Med 1983; 308: 420–424
   PubMed Web of Science ®Google Scholar
• Amino N, Yuasa T, Yabu Y, Miyai K, Kumahara Y. Exophthalmus in autoimmune thyroid disease. J Clin Endocrinol Metab 1980; 51: 1232–1234
   PubMed Web of Science ®Google Scholar
• Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall J R. Demonstration of a circulating autoanti-body against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet 1982; II: 1353–1356
   Google Scholar
• Kohn L D, Alvarez F, Marocci C, Kohn A D, Corda D, Hoffman W E, et al. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease. Ann NY Acad Sci 1986; 475: 157–173
   PubMed Web of Science ®Google Scholar
• Wall J R, Kuroki T. Immunological factors in thyroid disease. Med Clin North Am 1985; 69: 913–936
   Google Scholar
• Farid N R, Stone E, Johnson G. Graves' disease and HLA: Clinical and epideiologic associations. Clin Endocrinol 1980; 15: 535–544
   Google Scholar
• Werner S C. Classification of eye changes of Graves' disease. Clin Endocrinol Metab 1969; 29: 982–984
   Google Scholar
• Werner S C. Modification of the classification of eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association. Clin Endocrinol Metab 1977; 44: 203–204
   Google Scholar
• Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid N R. Genetic factors in Graves' opthalmopathy. Clin Endocrinol 1986; 25: 479–485
   PubMed Web of Science ®Google Scholar
• Mittal K D, Mickey M R, Singal D P, Tersaki P I. Serotyping for homotransplation XVIII Refinement of microdroplet lymphocyte cytoxicity test. Transplantation 1968; 6: 913–927
   PubMed Web of Science ®Google Scholar
• Farid N R, Thompson C. HLA and autoimmune endocrine disease. Mol Biol Med 1986; 3: 85–97
   PubMedGoogle Scholar
• Baur M P, Danilos A J. Population analysis of HLA-A, B, C, DR and other genetics. Histocompatibility Testing 1980, P I Terasaki. UCLA Press, Los Angeles 1980; 955–993
   Google Scholar
• Larsen B, Arnason A, Barnard J M, Buehler S K, Marshall W H. Bf types and HLA haplotyped individuals in an isolated Newfoundland population. Tissue Antigens 1977; 10: 403–409
   Google Scholar
• Awdeh Z L, Alper C A. Inherited structural polymorphism of the fourth component of human complement (C4). Proc Natl Acad Sci USA 1980; 77: 3576–3580
   PubMed Web of Science ®Google Scholar
• Skanes V M, Barnard J, Farid N, Marshall W H, Murphy L, Rideout D, Taylor R, Xideos G, Larsen B. Class III Alleles and High-risk MHC Haplotypes in Type I Diabetes Mellitus, Graves' Disease and Hashimoto's Thyroiditis. Mol Biol Med 1986; 3: 143–157
   Google Scholar
• Woolf B. On estimating the relation between the blood groups and disease. Ann Hum Genet 1955; 19: 251–253
   PubMed Web of Science ®Google Scholar
• Svejgaard A, Platz P, Ryder L P. HLA and disease 1982- A survey. Immunol Rev 1983; 70: 193–218
   PubMed Web of Science ®Google Scholar
• Menitten O S. Estimobility and estimation in case-referent studies. Amer J Epidemiol 1976; 103: 226–235
   Google Scholar
• Trowsdale J, Young J AT, Kelly A P, Austin P J, Carson S, Meunier M, et al. 1985. Structure, sequence and polymorphism in the HLA-D region. Immunol Rev 1985; 85: 5–43
   PubMedGoogle Scholar
• Albert E D, Baur M P, Mayr WR. Histocompatibi[ity Testing1984. Springer-Verlag, Berlin 1984
   Google Scholar
• Allannic H, Faychet R, Lorcy Y, Heim J, Gueguen M, Leguerrier A, Genetat B. HLA and Graves' Disease: An association with HLA-DRw3. J Clin Endocrinol Metab 1980; 51: 863–867
   Google Scholar
• Svejgaard A, Jakobsen B K, Platz P, Ryder L P, Nerup J, Christy M, et al. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 1986; 28: 237–244
   PubMedGoogle Scholar
• Scherthaner G, Ludwig H, Mayr W R. Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy. Diabet Metab 1977; 3: 189
   Google Scholar
• Wang P W, Hiromatsu Y, Laryea E, Wosu L, How J, Wall J R. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J CIin Endocrinol Metab 1986; 63: 316–322
   PubMed Web of Science ®Google Scholar
• Lanier L L, Phillips J H. Evidence for three types of human cytotoxic lymphocytes. Immunol today 1986; 7: 132–133
   PubMedGoogle Scholar
• Wegelius O, Asboe-Hansen G, Lamberg B A. Retrobulbar connective tissue changes in malignant exophthalmos. Acta Endocrinologica 1975; 25: 452–456
   Google Scholar
• Riley F C. Orbital pathology in Graves' disease. Mayo Clin Proc 1972; 47: 975–979
   Web of Science ®Google Scholar
• Munro R E, Lamki L, Row V V, Volpe R. Cell-mediated immunity in the exophthalmus of Graves' disease as demonstrated by migration inhibition factor (MIF) test. J Ch Endocrinol Metab 1973; 37: 286–292
   PubMed Web of Science ®Google Scholar
• Mahieu R, Winand R. Demonstration of delayed hypersensitivity in retrobulbar and thyroid tissues in human exophthalmus. J Clin Endocrinol Metab 1972; 34: 1009–1092
   Google Scholar
• Rose N R. The genetic basis of susceptibility to autoimmune disease. HLA in Endocrine and Metabolic Disorders, N R Farid. Academic Press, New York 1981; 1–10
   Google Scholar
• Stenszky V, Balazs C, Kozma L, Leovey A, Farid N R. HLA control of thyroglobulin-induced blast-transformation in Graves' disease. Hum Hered 1981; 31: 322–324
   Google Scholar